Active Spectrum Micro-ESR acquired by Bruker

Bruker today announced that it has acquired Active Spectrum Inc. in Foster City, California, the inventor and manufacturer of innovative benchtop micro-ESR (Electron Spin Resonance) spectroscopy systems used for chemistry teaching and research, as well as for applied and industrial applications.  Financial terms of the acquisition were not disclosed.

microESR_vs3

The compact and fully integrated micro-ESR systems developed by Active Spectrum expand Bruker’s existing research and high-end ESR product line with unique, robust and easy-to-use benchtop discrete sample or on-line ESR systems, with remarkably good performance.

Active Spectrum’s micro-ESR systems will be integrated into Bruker’s ESR/EPR portfolio and distributed via Bruker’s global sales, service and channel partner network into applied, industrial and education markets.

ESR is used for the detection of paramagnetic species, and its applications include the analysis of petroleum and lubricants, industrial sensing applications that include the detection of reactive oxygen and nitrogen species. In addition, micro-ESRs are excellent teaching tools and can be used for undergraduate chemistry research.

With this acquisition, Bruker has strengthened its expertise and leadership in benchtop and on-line ESR.  Active Spectrum’s unique, performance-leading micro-ESR systems offer an outstanding platform to develop tailored solutions for the industrial and applied markets using very compact magnetic resonance technology.”

Dr. Iris Mangelschots, President of the Bruker BioSpin Applied, Industrial & Clinical Division.

James R. White, Ph.D., President and Co-Founder of Active Spectrum Inc., commented: “I am delighted that Bruker, a leader in magnetic resonance known for innovation and dedication to excellence, has acquired our micro-ESR business. We are thrilled that our novel and innovative approach to this technology has been recognized and adopted by Bruker. The addition of our micro-ESR systems to their portfolio will give our customers a wide range of options, backed by Bruker’s global support and service. We are excited to continue to develop new micro-ESR applications for robust, effective and affordable benchtop solutions for applied and industrial markets.”

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bruker BioSpin - NMR, EPR and Imaging. (2019, June 24). Active Spectrum Micro-ESR acquired by Bruker. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20170109/Active-Spectrum-Micro-ESR-acquired-by-Bruker.aspx.

  • MLA

    Bruker BioSpin - NMR, EPR and Imaging. "Active Spectrum Micro-ESR acquired by Bruker". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20170109/Active-Spectrum-Micro-ESR-acquired-by-Bruker.aspx>.

  • Chicago

    Bruker BioSpin - NMR, EPR and Imaging. "Active Spectrum Micro-ESR acquired by Bruker". News-Medical. https://www.news-medical.net/news/20170109/Active-Spectrum-Micro-ESR-acquired-by-Bruker.aspx. (accessed April 25, 2024).

  • Harvard

    Bruker BioSpin - NMR, EPR and Imaging. 2019. Active Spectrum Micro-ESR acquired by Bruker. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20170109/Active-Spectrum-Micro-ESR-acquired-by-Bruker.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Bruker-Biognosys collaboration aims to deliver advanced proteomics CRO services